Home › Sclerosing Cholangitis › Washington
Sclerosing Cholangitis clinical trials in Washington
4 studies for Sclerosing Cholangitis are looking for participants at sites in Washington.
Cities in Washington
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Northwest Gastroenterology Associates, Bellevue
- Velocity Clinical Research, Seattle, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- Seattle Children's Hospital, Seattle
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT05750498Primary Sclerosing Cholangitis in Children
- Seattle Children's Hospital, Seattle
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- Liver institute Northwest, Seattle
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 24, 2025 · NCT06699121From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.